Completed
A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted
NCT03547245
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- George Washington University Washington D.C., District of Columbia, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States